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 Abstract                                                                                                            
Familial Mediterranean Fever (FMF) is a hereditary 
autoinflammatory disease with autosomal recessive inheritance 
pattern often seen around the Mediterranean Sea. It is characterized 
by recurrent episodes of fever and polyserositis and rash. Recently, 
MEFV gene analysis determines the definitive diagnosis of FMF. 
In this study, we analyzed 12 MEFV gene mutations in more 
than 200 FMF patients, previously diagnosed by Tel-Hashomer 
clinical criteria, in northwest of Iran, located in the proximity of the 
Mediterranean Sea. In the northwest of Iran (Ardabil), 216 patients 
with FMF diagnosis, based on Tel-Hashomer criteria, referred to the 
genetic laboratory to be tested for the following mutations; P369S, 
F479L, M680I(G/C), M680I(G/A), I692del, M694V, M694I, K695R, 
V726A, A744S, R761H, E148Q. All patients were screened for 
MEFV gene mutations by a reverse hybridization assay (FMF Strip 
Assay, Vienna lab, Vienna, Austria) according to manufacturer’s 
instructions. Among these FMF patients, no mutation was detected 
in 51 (23/62%) patients, but 165 (76/38%) patients had one or 
two mutations, 33 patients (15/28%) homozygous, 86 patients 
(39/81%) compound heterozygous and 46 patients (21/29%) were 
heterozygous. The most common mutations were M694V (23/61%), 
V726A (11/11%) and E148Q (9/95%) respectively.
MEFV gene mutations showed similarities and dissimilarities 
in different ethnic groups, while it is common among Arabs and 
Armenians genotype. Since common 12 MEFV gene analysis 
could not detect up to 50% of our patients, who had FMF on the 
basis of clinical Tel-Hashomer criteria, clinical criteria is still the 
best way in the diagnosis of FMF in this area.
The abstract of this article has been presented in the 7th Congress of 
International Society of Systemic Auto-Inflammatory Diseases in Lausanne, 
Switzerland, 22-26 May 2013.
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 Introduction                                                                                            
Familial Mediterranean fever (FMF) is a hereditary recurrent 
inflammatory disease with autosomal recessive pattern of inheritance 
characterized by self-limiting recurrent fever and pain in the serous 
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membranes, pleurisy, peritonitis, arthritis and 
erythema.1,2 The most important complication of 
FMF is amyloidosis that eventually leads to kidney 
failure.3 Symptoms can occur in the first 10 years 
of life and according to the recent study in more 
than 80 percent of patients, the symptoms appear 
in childhood era.1
FMF is often presented in people of 
Mediterranean ancestry.4 The disease is 
mostly seen among Turks, Arabs, Armenians, 
and Jews.5 Gene associated with the disease 
(Mediterranean Fever) MEFV gene was 
detected in 1997, it is located on the short arm 
of chromosome 16(16p13). The MEFV gene 
encodes pyrin, a protein expressed in neutrophils, 
eosinophils, monocytes, dendritic cells, and 
fibroblasts. In monocytes, pyrin co-localized with 
the microtubule system. This fact may contribute 
to the therapeutic effect of colchicine, which 
destabilizes the cytoskeleton. The exact role 
for pyrin and the mechanisms by which MEFV 
mutations (more than 300 variants) exert their 
pathogenic effects are inadequately understood. 
Initial diagnosis of FMF is mainly based on clinical 
Tel-Hashomer criteria, as described below.6
Definitive diagnosis requires at least two major 
criteria or one major and two minor criteria:
Major criteria
● Fever with peritonitis, synovitis, or pleurisy 
● Recurrent febrile attacks
● AA amyloidosis (without risk factors or other 
chronic inflammatory diseases)
Minor criteria
● Erysipeloid erythema
● Response to colchicine 
● Family history of periodic syndrome
While identifying MEFV gene mutations 
determines the definitive diagnosis of FMF, clinical 
manifestations of the disease is much more 
sensitive and specific to diagnosis, especially in 
practice. It should be kept in mind that failure to 
find mutations in the MEFV gene does not rule 
out the disease.6
Bonyadi, in a cohort of 200 unrelated healthy 
individuals, screened for the five most common 
MEFV mutations (M694V, V726A, M680I, M694I, 
and E148Q). In this genotyping, the carrier rate 
among the Azeri people was 25.5%, with E148Q 
(11.5%) followed by V726A (1.75%). This study 
showed that E148Q mutation and carrier rate 
are high among the Iranian-Azeri people. The 
remaining common mutations were not found in 
this cohort.3
The allele frequency of MEFV gene mutations 
has high heterogeneity among the Turkish 
population and they are believed to be a high-risk 
population for developing FMF. The carrier-state 
frequency of FMF is 20%. The five most common 
mutations in the MEFV gene are M694V, E148Q, 
M680I, V726A, and M694I.7
This study is conducted to evaluate 12 common 
MEFV gene mutations in FMF patients (with 
documented FMF) to design a common MEFV 
gene profile. Additionally, we aimed at evaluating 
the diagnostic value of Tel-Hashomer clinical 
criteria versus genetic study in patients living in 
the northwest of Iran (near the Mediterranean 
Sea) having Azeri-Turkish background.
 Materials and Methods                                                                                           
Based on the Tel-Hashomer clinical criteria, 300 FMF 
diagnosed patients enrolled in this descriptive case 
series study during August 2011 to September 2012. 
The study took place at a FMF clinic in northwest 
of Iran and the participants were selected among 
the Azeri-Turkish community in Ardabil. In total, 216 
patients participated in the study; among which 84 
patients were unavailable, unwilling, or not prepared 
to fill-in the consent form. This study was approved 
by the Ethical Committee of the Medical Faculty.
The patients were investigated and screened 
for the 12 known FMF mutations by a reverse 
hybridization assay (FMF StripAssay, Vienna 
lab, Vienna, Austria) according to manufacturer’s 
instructions. About 100 ml of peripheral blood 
was used for extracting DNA by boiling-based 
method. Initially, exons 2, 3, 5 and 10 were 
amplified for each patient in a single and multiplex 
PCR, with the primers supplied in the RDB kit. 
The thermocycling program of amplification 
was 35 cycles (94ºC for 15 seconds, 58ºC for 
45 seconds, and 72ºC for 45 seconds) and a 
final extension at 72ºC for 7 minutes. Agarose 
electrophoresis revealed the accuracy of the 
amplification by detecting four amplified DNA 
fragments, including 206, 236, 295, and 318 bp. 
In a test strip presenting a parallel array of allele-
specific oligonucleotide probes, biotinylated PCR 
products were selectively hybridized. By this 
means, the twelve common mutations E148Q 
in exon 2, P369S in exon 3, F479L in exon 5 
and M680I (G/C), M680I (G/A), I692del, M694V, 
M694I, K695R, V726A, A744S, and R761H in 
exon 10 were determined.
Statistical analysis was performed using 
SPSS V 15.0. Comparison between the different 
genotypes was assessed using a chi-square test. 
P=0.05 was accepted as statistically significant. 
 Results                                                                                          
Among the 216 patients, 121 patients (56.01%) 
were male and 95 patients (43.99%) were female. 
The mean age of patients was 19-59 years and 
with a range from young infant (3 months) to 74 
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years of age. In this study, abdominal pain in 205 
(95%), fever in 200 (93%), arthritis in 9 (4.33%), and 
chest pain in 5 (2.33%) were observed. 51 patients 
(23.62%) had no mutation, 165 patients (76.38%) 
have one or two mutations. Among these, 33 
patients (15.28%) were homozygous, 46 patients 
(21.29%) heterozygous and 86 patients (39.81%) 
were compound heterozygous. As shown in table 
1, thirty different genotypes were identified. Five 
mutations, M694V (23.61%), V726A (11.11%), 
E148Q (9.95%), M680I (9.02%) and R761H (3.47%) 
were the most common mutations in this study 
(table 2). The I692del, V761R, R726A mutations 
were rare and only detected in three patients. 
There was no significant difference between results 
for male and female; however, there were some 
similarities and dissimilarities in comparison with 
other studies (table 3-5).
 Discussion                                                                                          
In 216 FMF patients, 51 patients (23.62%) had no 
mutations, 46 patients (21.29%) heterozygous, 86 
patients (39.81%) compound heterozygous and 33 
patients (15.28%) were homozygous (table 2). The 
most common mutation was M694V (23.61%) and 
in the second place was the V726A (11.11%), as 
shown in table 2.
In comparison with different ethnic groups 
as well as different studies, the 12 common 
Table 1: Distribution of the MEFV gene mutations
Mutation Genotype Number %
Heterozygote E148Q 18 8.33
(n=46) M694V 14 6.48
(21/29%) V726A 4 1.85
A744S 4 1.85
M680I 3 1.38
P369S 2 0.92
R761H 1 0.46
Homozygote M694V 18 8.33
(n=33) M680I 9 4.16
(15/28%) E148Q 3 1.3
M694I 1 0.46
V726A 1 0.46
R761H 1 0.46
Compound heterozygote M694V-V726A 24 11.11
(n=86) E148Q-M694V 11 5.09
(39/81%) M680I-V726A 8 3. 70
R761H-M694V 8 3.70
M680I-M694V 5 2.31
V726A-R761H 5 2.3
M694V-M694I 4 1.85
M680I-R761H 4 1.85
E148Q-P396S 3 1.38
M694V-P396S 3 1.38
K694R-V726A 2 0.92
A744S-R761H 2 0.92
E148Q-V726A 2 0.92
V726A-M694I 2 0.92
M680I-M694I 1 0.46
M694I-R761H 1 0.46
I162del-R761H 1 0.46
Patients with no identified mutation 51 23.62
Table2: The most common MEFV gene mutation frequency
Mutation Number of alleles Frequency (%)
M694V 102 23.61
V726A 48 11.11
E148Q 43 9.95
M680I 39 9.02
R761H 15 3.47
M694I 13 3
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MEFV gene mutations show similarities and 
dissimilarities (table 3 and 4). In all ethnic groups, 
M694V was the most common mutation. M680I 
was the second most common mutation among 
the Turks, whereas V726A was the second 
mutation among the Jews, Armenians, Arabs, 
and Iranian-Azeri. While M6941 is common 
among Arabs and least frequent among Jews, it 
displayed a higher rate among the Iranian-Azeri. 
Except E148Q mutation, it seems that Armenians 
and the population in our study have the same 
pattern of mutations, although the frequency of 
MEFV gene is similar to Arabs.
Bonyadi showed high frequency of E148Q in 
normal Azeri people, but our study represents 
significant frequency of this mutation in FMF 
patients as well (table 5).8
In this study, common compound mutations 
were M694V-V726A (11.11%), M694V-M694V 
(8.33%), and E148Q-M694V (5.09%) respectively. 
However, in other studies7-10 M694V-M694V is the 
most common mutation. Turkish researchers7,9 
showed that M694V-M680I is the second 
common compound mutation, however, Azeri-
Turkish studies8,10 showed that M694V-V726A is 
the second common compound mutation. 
In the present study, we rarely observed 
V761R, R726A, and I692del with one mutation. 
Furthermore, there are no reports on the 
compound heterozygote mutations K694A/
V726A, M694I/R761H, I692del/R761H, and 
A744S/R761H, as the case in our patients. 
The key point in this study is the re-evaluation 
of MEFV gene in the diagnosis of FMF since 
we could only detect 55.09% of those patients 
suffering from FMF (by 12 common MEFV gene 
analysis). It seems that clinical criteria are still the 
best method in the diagnosis of FMF. In addition, 
molecular analysis of FMF mutations in Chetrit’s 
study confirmed the diagnosis in about 60% of the 
referrals with suspected FMF.12 Some individuals 
with paired MEFV mutations do not have clinical 
symptoms13 and one molecular study showed 
diagnosis of FMF was unlikely in 7% of patients 
based on clinical criteria.14
Many diagnostic criteria for FMF were initially 
developed for adults (Tel-Hashomer criteria and 
Livneh criteria) and then for children (Yalcinkaya 
criteria). All criteria have high sensitivity, but 
low specificity; particularly in the pediatric age 
Table 3: Mutations in different studies
Study Number of
Patients
Mutation frequencies (%) Number of mutations
Heterozygous Compound Heterozygous Homozygous
Dundar7 2067 26.41 15.29 8.60 49.60
Yilmaz9 78 28 36 32 4
Esmaeili8 190 22.10 19.47 21.57 36.84
Bonyadi10 524 21.37 28.81 17.17 32.65
Balci11 25 18 24 12 46
Our study 216 21.29 39.81 15.28 23.62
Table 4: Comparison of allele frequencies in similar studies
Study Mutation frequencies (%)
M694V V726A M680I M694I E148Q
Dundar7 14.68 4.76 7.62 0.46 5.15
Yilmaz9 55 3 16 0 10
Balci11 38 4 8 0 4
Bonyadi10 42.4 17 15.2 2.2 16.2
Esmaeili8 28 9 7 1 7
Our study 23.61 11.11 9.02 3 9.95
Table 5: Frequency of the fivemost common MEFV gene mutations among different ethnic groups
Ethnic group M694V V726A M680I* M694I E148Q Overall frequency (%)**
Jews 77 12.3 0.6 0 10.2 51
Armenians 52 26 20 0.2 1.8 94
Arabs 42.5 23.1 9.6 14.1 10.7 47
Turks 71.3 8.5 15 1.7 3.5 68
Iranian-Azeri Turks 54 16.7 12.6 2.5 14.2 52
Our study 23.61 11.11 9.02 3 9.95 57
*In some references, both G to C and G to A were studied; **The fraction of identifiable mutations among all independent alleles 
regarding the five common mutations
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group where recurrent fever attacks are more 
common than in adults. Since the identification 
of the MEFV gene, considerable progress has 
been made in the understanding of FMF. To date, 
more than 300 sequence variants (mutations and 
polymorphisms) have been identified in MEFV 
gene. Gene analysis test is a valuable diagnostic 
tool, but is still unable to confirm diagnosis in all 
patients. Consequently, more attention should 
be given to the clinical diagnostic criteria.15 As a 
whole, a new moleculo-clinical approach to FMF 
is inevitable in the future.
 Conclusion                                                                                          
M694V is the most common mutation, and M694V-
V726A is the most common compound in northwest 
of Iran. MEFV gene frequency is similar to studies 
on Arabs and Armenians. It is concluded that 
clinical criteria are the best way in FMF diagnosis.
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